Blog

FDA Misses Key Hemp Deadline: Federal Regulatory Limbo Sparks Industry Crisis February 2026 delivered a major shock to the hemp-derived cannabinoid economy: the U.S. Food and Drug Administration (FDA) missed a congressionally mandated deadline tied to federal hemp oversight. The agency was expected to publish specific cannabinoid lists and clarify [...]